Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Tout Cancer
- | Specialty :
- Thérapies Ciblées
Extract
MK7339-002 - A phase 2 study of olaparib monotherapy in participants with previously treated, homologous recombination repair mutation (HRRM) or homologous recombination deficiency (HRD) positive advanced cancer